{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:12:43Z","timestamp":1707523963808},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,17]]},"DOI":"10.7759\/cureus.47228","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:00:52Z","timestamp":1697587252000},"source":"Crossref","is-referenced-by-count":0,"title":["Physician Trainees' Perception of Cannabidiol Use in Medicine: A Survey Study"],"prefix":"10.7759","author":[{"given":"Alexandra","family":"Boyd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajith","family":"Malige","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orr","family":"Limpisvasti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-006-0033-x","article-title":"Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors","volume":"372","author":"Kathmann M","year":"2006","unstructured":"Kathmann M, Flau K, Redmer A, Tr\u00e4nkle C, Schlicker E. Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors. Naunyn Schmiedebergs Arch Pharmacol. 2006, 372:354-61. 10.1007\/s00210-006-0033-x","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.5435\/JAAOS-D-19-00767","article-title":"State medical cannabis laws associated with reduction in opioid prescriptions by orthopaedic surgeons in Medicare Part D cohort","volume":"29","author":"Lopez CD","year":"2021","unstructured":"Lopez CD, Boddapati V, Jobin CM, Hickernell TR. State medical cannabis laws associated with reduction in opioid prescriptions by orthopaedic surgeons in Medicare Part D cohort. J Am Acad Orthop Surg. 2021, 29:e188-97. 10.5435\/JAAOS-D-19-00767","journal-title":"J Am Acad Orthop Surg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s42238-022-00154-9","article-title":"Cannabidiol as a treatment for arthritis and joint pain: an exploratory cross-sectional study","volume":"4","author":"Frane N","year":"2022","unstructured":"Frane N, Stapleton E, Iturriaga C, Ganz M, Rasquinha V, Duarte R. Cannabidiol as a treatment for arthritis and joint pain: an exploratory cross-sectional study. J Cannabis Res. 2022, 4:47. 10.1186\/s42238-022-00154-9","journal-title":"J Cannabis Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpa.2020.06.004","article-title":"Use of cannabidiol (CBD) for the treatment of chronic pain","volume":"34","author":"Urits I","year":"2020","unstructured":"Urits I, Gress K, Charipova K, et al.. Use of cannabidiol (CBD) for the treatment of chronic pain. Best Pract Res Clin Anaesthesiol. 2020, 34:463-77. 10.1016\/j.bpa.2020.06.004","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2020.01.077","article-title":"Use of tetrahydrocannabinol and cannabidiol products in the perioperative period around primary unilateral total hip and knee arthroplasty","volume":"35","author":"Runner RP","year":"2020","unstructured":"Runner RP, Luu AN, Nassif NA, Scudday TS, Patel JJ, Barnett SL, Gorab RS. Use of tetrahydrocannabinol and cannabidiol products in the perioperative period around primary unilateral total hip and knee arthroplasty. J Arthroplasty. 2020, 35:S138-43. 10.1016\/j.arth.2020.01.077","journal-title":"J Arthroplasty"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2217\/pmt-2021-0018","article-title":"Rates of self-directed perioperative cannabidiol use in patients undergoing total hip or knee arthroplasty","volume":"11","author":"Yu JS","year":"2021","unstructured":"Yu JS, Premkumar A, Liu S, Sculco P. Rates of self-directed perioperative cannabidiol use in patients undergoing total hip or knee arthroplasty. Pain Manag. 2021, 11:655-60. 10.2217\/pmt-2021-0018","journal-title":"Pain Manag"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnx222","article-title":"The association between cannabis use and aberrant behaviors during chronic opioid therapy for chronic pain","volume":"19","author":"DiBenedetto DJ","year":"2018","unstructured":"DiBenedetto DJ, Weed VF, Wawrzyniak KM, et al.. The association between cannabis use and aberrant behaviors during chronic opioid therapy for chronic pain. Pain Med. 2018, 19:1997-2008. 10.1093\/pm\/pnx222","journal-title":"Pain Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.13152","article-title":"Interaction between warfarin and cannabis","volume":"124","author":"Damkier P","year":"2019","unstructured":"Damkier P, Lassen D, Christensen MM, Madsen KG, Hellfritzsch M, Potteg\u00e5rd A. Interaction between warfarin and cannabis. Basic Clin Pharmacol Toxicol. 2019, 124:28-31. 10.1111\/bcpt.13152","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2020.5545","article-title":"Perioperative cannabis as a potential solution for reducing opioid and benzodiazepine dependence","volume":"156","author":"Stewart C","year":"2021","unstructured":"Stewart C, Fong Y. Perioperative cannabis as a potential solution for reducing opioid and benzodiazepine dependence. JAMA Surg. 2021, 156:181-90. 10.1001\/jamasurg.2020.5545","journal-title":"JAMA Surg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5435\/JAAOSGlobal-D-21-00047","article-title":"Knowledge and opinion on cannabinoids among orthopaedic traumatologists","volume":"5","author":"Chin G","year":"2021","unstructured":"Chin G, Etiz BA, Nelson AM, Lim PK, Scolaro JA. Knowledge and opinion on cannabinoids among orthopaedic traumatologists. J Am Acad Orthop Surg Glob Res Rev. 2021, 5:10.5435\/JAAOSGlobal-D-21-00047","journal-title":"J Am Acad Orthop Surg Glob Res Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2196\/jmir.6.3.e34","article-title":"Improving the quality of web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES)","volume":"6","author":"Eysenbach G","year":"2004","unstructured":"Eysenbach G. Improving the quality of web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). J Med Internet Res. 2004, 6:e34. 10.2196\/jmir.6.3.e34","journal-title":"J Med Internet Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3928\/01477447-20191212-07","article-title":"Characteristics of marijuana use among orthopedic patients","volume":"43","author":"Carney JJ","year":"2020","unstructured":"Carney JJ, Hwang A, Heckmann N, Bernstein M, Marecek GS. Characteristics of marijuana use among orthopedic patients. Orthopedics. 2020, 43:108-12. 10.3928\/01477447-20191212-07","journal-title":"Orthopedics"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5435\/JAAOSGlobal-D-20-00172","article-title":"Prevalence of cannabinoid use in patients with hip and knee osteoarthritis","volume":"5","author":"Deckey DG","year":"2021","unstructured":"Deckey DG, Lara NJ, Gulbrandsen MT, Hassebrock JD, Spangehl MJ, Bingham JS. Prevalence of cannabinoid use in patients with hip and knee osteoarthritis. J Am Acad Orthop Surg Glob Res Rev. 2021, 5:10.5435\/JAAOSGlobal-D-20-00172","journal-title":"J Am Acad Orthop Surg Glob Res Rev"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/23259671221087629","article-title":"Prevalence of cannabinoid (CBD) use in orthopaedic sports medicine patients","volume":"10","author":"Deckey DG","year":"2022","unstructured":"Deckey DG, Doan M, Hassebrock JD, et al.. Prevalence of cannabinoid (CBD) use in orthopaedic sports medicine patients. Orthop J Sports Med. 2022, 10:10.1177\/23259671221087629","journal-title":"Orthop J Sports Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris PA","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, et al.. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019, 95:103208. 10.1016\/j.jbi.2019.103208","journal-title":"J Biomed Inform"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris PA","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009, 42:377-81. 10.1016\/j.jbi.2008.08.010","journal-title":"J Biomed Inform"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.22454\/FamMed.2020.645274","article-title":"Education and attitudes on medical cannabis in family medicine residency programs","volume":"52","author":"Philbrick AM","year":"2020","unstructured":"Philbrick AM, Danner C, Oyenuga A, Pereira C, Ricco J, Wendling AL. Education and attitudes on medical cannabis in family medicine residency programs. Fam Med. 2020, 52:730-5. 10.22454\/FamMed.2020.645274","journal-title":"Fam Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.08.010","article-title":"Physicians-in-training are not prepared to prescribe medical marijuana","volume":"180","author":"Evanoff AB","year":"2017","unstructured":"Evanoff AB, Quan T, Dufault C, Awad M, Bierut LJ. Physicians-in-training are not prepared to prescribe medical marijuana. Drug Alcohol Depend. 2017, 180:151-5. 10.1016\/j.drugalcdep.2017.08.010","journal-title":"Drug Alcohol Depend"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3122\/jabfm.2013.01.120089","article-title":"Colorado family physicians' attitudes toward medical marijuana","volume":"26","author":"Kondrad E","year":"2013","unstructured":"Kondrad E, Reid A. Colorado family physicians' attitudes toward medical marijuana. J Am Board Fam Med. 2013, 26:52-60. 10.3122\/jabfm.2013.01.120089","journal-title":"J Am Board Fam Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1089\/can.2017.0046","article-title":"New York physicians\u2019 perspectives and knowledge of the State Medical Marijuana Program","volume":"3","author":"Sideris A","year":"2018","unstructured":"Sideris A, Khan F, Boltunova A, Cuff G, Gharibo C, Doan LV. New York physicians\u2019 perspectives and knowledge of the State Medical Marijuana Program. Cannabis Cannabinoid Res. 2018, 3:74-84. 10.1089\/can.2017.0046","journal-title":"Cannabis Cannabinoid Res"},{"key":"ref21","unstructured":"Drug Enforcement Administration. List of controlled substances. Controlled substance schedules. (2023). https.\/\/www.deadiversion.usdoj.gov\/schedules\/."},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2014.991858","article-title":"Stigma among California's medical marijuana patients","volume":"47","author":"Satterlund TD","year":"2015","unstructured":"Satterlund TD, Lee JP, Moore RS. Stigma among California's medical marijuana patients. J Psychoactive Drugs. 2015, 47:10-7. 10.1080\/02791072.2014.991858","journal-title":"J Psychoactive Drugs"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000001929","article-title":"Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials","volume":"162","author":"Fisher E","year":"2021","unstructured":"Fisher E, Moore RA, Fogarty AE, et al.. Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials. Pain. 2021, 162:S45-66. 10.1097\/j.pain.0000000000001929","journal-title":"Pain"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/pde.13545","article-title":"Self-initiated use of topical cannabidiol oil for epidermolysis bullosa","volume":"35","author":"Chelliah MP","year":"2018","unstructured":"Chelliah MP, Zinn Z, Khuu P, Teng JM. Self-initiated use of topical cannabidiol oil for epidermolysis bullosa. Pediatr Dermatol. 2018, 35:e224-7. 10.1111\/pde.13545","journal-title":"Pediatr Dermatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2017.06.005","article-title":"Topical medical cannabis: a new treatment for wound pain\u2014three cases of pyoderma gangrenosum","volume":"54","author":"Maida V","year":"2017","unstructured":"Maida V, Corban J. Topical medical cannabis: a new treatment for wound pain\u2014three cases of pyoderma gangrenosum. J Pain Symptom Manage. 2017, 54:732-6. 10.1016\/j.jpainsymman.2017.06.005","journal-title":"J Pain Symptom Manage"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.RVW.21.00184","article-title":"Marijuana in orthopaedics: effects on bone health, wound-healing, surgical complications, and pain management","volume":"10","author":"Heath DM","year":"2022","unstructured":"Heath DM, Koslosky EJ, Bartush KC, Hogue GD. Marijuana in orthopaedics: effects on bone health, wound-healing, surgical complications, and pain management. JBJS Rev. 2022, 10:e21.00184. 10.2106\/JBJS.RVW.21.00184","journal-title":"JBJS Rev"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.818","article-title":"Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis","volume":"20","author":"Hammell DC","year":"2016","unstructured":"Hammell DC, Zhang LP, Ma F, Abshire SM, McIlwrath SL, Stinchcomb AL, Westlund KN. Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis. Eur J Pain. 2016, 20:936-48. 10.1002\/ejp.818","journal-title":"Eur J Pain"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2513","article-title":"Cannabidiol, a major non-psychotropic cannabis constituent enhances fracture healing and stimulates lysyl hydroxylase activity in osteoblasts","volume":"30","author":"Kogan NM","year":"2015","unstructured":"Kogan NM, Melamed E, Wasserman E, et al.. Cannabidiol, a major non-psychotropic cannabis constituent enhances fracture healing and stimulates lysyl hydroxylase activity in osteoblasts. J Bone Miner Res. 2015, 30:1905-13. 10.1002\/jbmr.2513","journal-title":"J Bone Miner Res"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1186\/s42238-021-00078-w","article-title":"Cannabidiol use and effectiveness: real-world evidence from a Canadian medical cannabis clinic","volume":"3","author":"Rapin L","year":"2021","unstructured":"Rapin L, Gamaoun R, El Hage C, Arboleda MF, Prosk E. Cannabidiol use and effectiveness: real-world evidence from a Canadian medical cannabis clinic. J Cannabis Res. 2021, 3:19. 10.1186\/s42238-021-00078-w","journal-title":"J Cannabis Res"},{"key":"ref30","unstructured":"FDA warns companies illegally selling over-the-counter CBD products for pain relief. (2021). https.\/\/www.fda.gov\/news-events\/press-announcements\/fda-warns-companies-illegally-selling-over-counter-cbd-products-p...."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/197427-physician-trainees-perception-of-cannabidiol-use-in-medicine-a-survey-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:52:52Z","timestamp":1707508372000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/197427-physician-trainees-perception-of-cannabidiol-use-in-medicine-a-survey-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,17]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.47228","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,17]]}}}